In summary, HB-EGF is highly expressed in lung cancer cells, especially LUAD, which leads to poor prognosis and is correlated with increased TIICs, including monocytes, macrophages, neutrophils, and DCs. This evidence concerns the gene HBEGF and lung carcinoma.